Ashland acquires ingredients maker Pharmachem Laboratories for $ 660 mn

Deal to strengthen Ashland's position in fast-growing nutraceuticals market

Ashland acquires ingredients maker Pharmachem Laboratories for $ 660 mn
BS B2B Bureau Covington, Kentucky (USA)
Last Updated : Apr 18 2017 | 11:36 AM IST
In an all-cash transaction, specialty chemicals company Ashland Global Holdings Inc has agreed to acquire privately owned Pharmachem Laboratories Inc, the US-based provider of ingredients to the global health and wellness industries and high-value differentiated products to fragrance and flavour houses, for $ 660 million. While Pharmachem is one of the leading suppliers to $ 39 billion vitamin and dietary supplement market, it operates one of the largest custom extraction facilities for natural ingredients in North America.

With annual revenues of approximately $ 300 million and 14 manufacturing facilities in the US and Mexico, New Jersey-based Pharmachem develops, manufactures and supplies custom and branded nutritional and fragrance products. The 38-year-old company sells to the end markets such as nutrition and health (43 percent of total sales); fragrance and flavours (33 percent); food, beverage & personal care (15 percent); and custom manufacturing (9 percent).

“The acquisition of Pharmachem offers a number of exciting growth opportunities in higher-margin end markets while also strengthening our specialty product line. This combination will enhance our position in fast-growing nutraceutical end markets, open a new opportunity within fragrances and flavours, and strengthen Ashland's food ingredient business by adding customised functional solutions. In combining Pharmachem and Ashland, we can leverage our extensive sales channels, technical service network and global applications labs to accelerate Pharmachem's growth,” commented William Wulfsohn, chairman and chief executive officer, Ashland.

Ashland anticipates achieving meaningful cost synergies from leveraging combined capabilities, as well as tax synergies driven by the integration of Pharmachem into Ashland's global business structure.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story